NCT02835664View on ClinicalTrials.gov

Nicotinamide Riboside and Metabolic Health

NACompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

ObesityInsulin Resistance

Interventions

DIETARY_SUPPLEMENT

Nicotinamide Riboside (Niagen)

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

Unknown

Maastricht University Medical Centre, Maastricht

Sponsors

Collaborators (1)

Dutch Heart Foundation

All Listed Sponsors

collaborator

Dutch Heart Foundation

OTHER

lead

Maastricht University Medical Center

OTHER